Published in Proc Natl Acad Sci U S A on January 26, 2009
Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol (2013) 3.77
Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol (2010) 3.67
Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events. Nat Immunol (2016) 2.23
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol (2010) 1.58
Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med (2010) 1.39
γδ T cells in cancer. Nat Rev Immunol (2015) 1.39
Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. Blood (2010) 1.38
A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog (2009) 1.35
The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice. J Exp Med (2011) 1.17
Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation. Front Immunol (2012) 1.15
Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor. Mol Ther (2013) 1.09
Prolonged antigen survival and cytosolic export in cross-presenting human gammadelta T cells. Proc Natl Acad Sci U S A (2010) 1.08
Defining the nature of human γδ T cells: a biographical sketch of the highly empathetic. Cell Mol Immunol (2012) 1.07
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat Med (2016) 1.06
γδ-T cells: an unpolished sword in human anti-infection immunity. Cell Mol Immunol (2012) 1.06
Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2 T cells increase resistance to tuberculosis in nonhuman primates. PLoS Pathog (2013) 1.02
Multifunctional immune responses of HMBPP-specific Vγ2Vδ2 T cells in M. tuberculosis and other infections. Cell Mol Immunol (2012) 1.01
Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits. J Immunol (2009) 0.99
γδ T cells and their potential for immunotherapy. Int J Biol Sci (2014) 0.97
Roles of γδ T cells in the pathogenesis of autoimmune diseases. Clin Dev Immunol (2013) 0.96
Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies. Cell Mol Immunol (2011) 0.96
Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol (2014) 0.91
Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells. Cell Mol Life Sci (2013) 0.90
Immune biology of Ag-specific γδ T cells in infections. Cell Mol Life Sci (2011) 0.89
Increased cholesterol content in gammadelta (γδ) T lymphocytes differentially regulates their activation. PLoS One (2013) 0.89
γδ T-cell immunotherapy for lung cancer. Surg Today (2011) 0.88
Hunting for clinical translation with innate-like immune cells and their receptors. Leukemia (2013) 0.86
Lipid peroxidation causes endosomal antigen release for cross-presentation. Sci Rep (2016) 0.86
T-cell-associated cellular immunotherapy for lung cancer. J Cancer Res Clin Oncol (2014) 0.84
The contribution of non-conventional T cells and NK cells in the mycobacterial-specific IFNγ response in Bacille Calmette-Guérin (BCG)-immunized infants. PLoS One (2013) 0.84
Plasticity of γδ T Cells: Impact on the Anti-Tumor Response. Front Immunol (2014) 0.83
Cancer Immunotherapy Using γδT Cells: Dealing with Diversity. Front Immunol (2014) 0.82
Intracellular Transport Routes for MHC I and Their Relevance for Antigen Cross-Presentation. Front Immunol (2015) 0.82
Licensing of γδT cells for professional antigen presentation: A new role for antibodies in regulation of antitumor immune responses. Oncoimmunology (2012) 0.81
Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation. Front Immunol (2015) 0.81
Vγ2Vδ2 T cell Costimulation Increases NK cell Killing of Monocyte-derived Dendritic Cells. Immunology (2014) 0.81
The Jekyll and Hyde story of IL17-Producing γδT Cells. Front Immunol (2015) 0.80
A novel strategy to screen Bacillus Calmette-Guérin protein antigen recognized by γδ TCR. PLoS One (2011) 0.79
γδ T cells response to Mycobacterium tuberculosis in pulmonary tuberculosis patients using preponderant complementary determinant region 3 sequence. Indian J Med Res (2011) 0.79
Identification of a new tuberculosis antigen recognized by γδ T cell receptor. Clin Vaccine Immunol (2013) 0.79
99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: evolution of adaptive immunity in vertebrates. Clin Exp Immunol (2010) 0.78
Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer. J Transl Med (2015) 0.78
Expanded Human Blood-Derived γδT Cells Display Potent Antigen-Presentation Functions. Front Immunol (2014) 0.78
Influence of endogamy and mitochondrial DNA on immunological parameters in cattle. BMC Vet Res (2014) 0.78
γδ T cell and other immune cells crosstalk in cellular immunity. J Immunol Res (2014) 0.77
Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects. J Immunol Res (2014) 0.77
Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy. Front Immunol (2014) 0.76
Comparative gamma delta T cell immunology: a focus on mycobacterial disease in cattle. Vet Med Int (2011) 0.76
Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins. F1000Res (2017) 0.75
γδ T cells in cancer immunotherapy. Oncotarget (2016) 0.75
Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res (2016) 0.75
Human γδ T cells augment antigen presentation in Listeria Monocytogenes infection. Mol Med (2016) 0.75
Regeneration of stalled immune responses to transformed and infected cells using γδ T cells. Drug Discov Today (2014) 0.75
Zoledronic acid boosts γδ T-cell activity in children receiving αβ(+) T and CD19(+) cell-depleted grafts from an HLA-haplo-identical donor. Oncoimmunology (2016) 0.75
Human γδT-cell subsets and their involvement in tumor immunity. Cell Mol Immunol (2016) 0.75
Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications. Front Immunol (2017) 0.75
Age dependent differences in the kinetics of γδ T cells after influenza vaccination. PLoS One (2017) 0.75
Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8(+) T cells. Immunol Cell Biol (2017) 0.75
γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations. J Immunol (2017) 0.75
Adoptively transferred Vγ9Vδ2 T cells show potent antitumor effects in a preclinical B cell lymphomagenesis model. JCI Insight (2017) 0.75
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
[gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol (2000) 5.01
Professional antigen-presentation function by human gammadelta T Cells. Science (2005) 3.77
Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol (2002) 3.64
Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol (2006) 3.57
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. J Exp Med (1999) 2.98
Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev (2005) 2.96
Deletion of CD4 and CD8 coreceptors permits generation of alphabetaT cells that recognize antigens independently of the MHC. Immunity (2007) 2.66
Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med (1995) 2.55
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev (2007) 2.46
Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. Annu Rev Immunol (2005) 2.39
Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett (2003) 2.30
Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med (2003) 2.16
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity (2000) 2.10
Prominence of gamma delta T cells in the ruminant immune system. Immunol Today (1991) 1.91
Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science (1990) 1.79
Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol Rev (2005) 1.71
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol Rev (2002) 1.58
Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection. Infect Immun (2007) 1.52
Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy. J Immunol (2007) 1.42
gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy (2005) 1.38
Flexible migration program regulates gamma delta T-cell involvement in humoral immunity. Blood (2003) 1.32
Activation of C-C beta-chemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cytokines. Blood (2000) 1.31
Mouse gammadelta T cells are capable of expressing MHC class II molecules, and of functioning as antigen-presenting cells. J Neuroimmunol (2008) 1.25
CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production. J Immunol (2006) 1.19
Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J Exp Med (1999) 1.14
Gammadelta T cells: an alternative type of professional APC. Trends Immunol (2006) 1.13
Gammadelta T cells present antigen to CD4+ alphabeta T cells. J Leukoc Biol (1998) 1.10
gammadelta T cells: novel initiators of adaptive immunity. Immunol Rev (2007) 1.09
Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. Int Immunol (2001) 1.05
A sub-population of circulating porcine gammadelta T cells can act as professional antigen presenting cells. Vet Immunol Immunopathol (2002) 0.97
The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Immunology (2006) 0.96
Processing of tumor-associated antigen by the proteasomes of dendritic cells controls in vivo T-cell responses. Cancer Res (2006) 0.96
The Pathway Tools software. Bioinformatics (2002) 14.89
A test of enhancing model accuracy in high-throughput crystallography. J Struct Funct Genomics (2005) 5.96
TLR3 deficiency in patients with herpes simplex encephalitis. Science (2007) 5.86
Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J (2005) 5.36
Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol (2005) 4.99
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest (2010) 4.22
Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity (2011) 3.97
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation (2002) 3.93
Professional antigen-presentation function by human gammadelta T Cells. Science (2005) 3.77
Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science (2006) 3.70
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res (2004) 3.59
Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients. J Clin Invest (2011) 3.28
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res (2007) 3.22
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol Immunother (2007) 3.16
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J Clin Invest (2005) 3.11
Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol (2008) 3.08
Crystal structure of the cytoskeleton-associated protein glycine-rich (CAP-Gly) domain. J Biol Chem (2002) 3.01
Tumour immunity: effector response to tumour and role of the microenvironment. Lancet (2008) 2.94
Coupled folding and binding with alpha-helix-forming molecular recognition elements. Biochemistry (2005) 2.94
"MIATA"-minimal information about T cell assays. Immunity (2009) 2.90
The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics (2008) 2.72
Dynamic superresolution imaging of endogenous proteins on living cells at ultra-high density. Biophys J (2010) 2.65
A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity (2009) 2.62
RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol (2003) 2.43
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol (2004) 2.30
Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A (2009) 2.27
Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat Immunol (2004) 2.18
Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum (2008) 2.15
Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci U S A (2003) 2.09
Extreme high temperatures and hospital admissions for respiratory and cardiovascular diseases. Epidemiology (2009) 2.06
High-affinity adaptors for switchable recognition of histidine-tagged proteins. J Am Chem Soc (2005) 2.06
Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol (2006) 2.02
Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J Immunol (2005) 2.01
The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes. FEBS Lett (2004) 1.93
Mining alpha-helix-forming molecular recognition features with cross species sequence alignments. Biochemistry (2007) 1.93
Spatiotemporal manipulation of auxin biosynthesis in cotton ovule epidermal cells enhances fiber yield and quality. Nat Biotechnol (2011) 1.93
A skin-selective homing mechanism for human immune surveillance T cells. J Exp Med (2004) 1.91
EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming. J Biol Chem (2006) 1.91
Cryo-EM model of the bullet-shaped vesicular stomatitis virus. Science (2010) 1.90
Harmonization of immune biomarker assays for clinical studies. Sci Transl Med (2011) 1.84
Structure and mechanism of ABC transporters. Curr Opin Struct Biol (2002) 1.84
Stochastic sensing of proteins with receptor-modified solid-state nanopores. Nat Nanotechnol (2012) 1.82
Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol (2009) 1.81
Cooperation of human tumor-reactive CD4+ and CD8+ T cells after redirection of their specificity by a high-affinity p53A2.1-specific TCR. Immunity (2005) 1.81
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions. Blood (2003) 1.78
Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor, P. Proc Natl Acad Sci U S A (2009) 1.78
D²P²: database of disordered protein predictions. Nucleic Acids Res (2012) 1.75
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site. J Immunol (2006) 1.74
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination. J Clin Invest (2009) 1.71
Melan-A/MART-1-specific CD8 T cells: from thymus to tumor. Trends Immunol (2002) 1.68
Integrins β1 and β3 exhibit distinct dynamic nanoscale organizations inside focal adhesions. Nat Cell Biol (2012) 1.66
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol (2011) 1.66
In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc Natl Acad Sci U S A (2007) 1.65
Pivotal role of dogs in rabies transmission, China. Emerg Infect Dis (2005) 1.64
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunol Immunother (2009) 1.63
Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen. Proc Natl Acad Sci U S A (2008) 1.59
Rational drug design via intrinsically disordered protein. Trends Biotechnol (2006) 1.57
Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res (2007) 1.55
Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL. Breast Cancer Res (2011) 1.54
In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses. J Clin Invest (2003) 1.54
Specific and stable fluorescence labeling of histidine-tagged proteins for dissecting multi-protein complex formation. J Am Chem Soc (2006) 1.53
The ATP hydrolysis cycle of the nucleotide-binding domain of the mitochondrial ATP-binding cassette transporter Mdl1p. J Biol Chem (2003) 1.52
MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity (2013) 1.51
The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology (Bethesda) (2004) 1.51
Improving protein order-disorder classification using charge-hydropathy plots. BMC Bioinformatics (2014) 1.50
Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46
Transcriptional profiling of Caulobacter crescentus during growth on complex and minimal media. J Bacteriol (2004) 1.46
Molecular mechanisms associated with Angiotensin-converting enzyme-inhibitory peptide activity on vascular extracellular matrix remodeling. Cardiology (2014) 1.45
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med (2010) 1.45
Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J Exp Med (2002) 1.44
Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP). J Biol Chem (2003) 1.42
Involvement of Arabidopsis histone deacetylase HDA6 in ABA and salt stress response. J Exp Bot (2010) 1.42
Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene (2002) 1.42
Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy. J Immunol (2007) 1.42
Conservation of intrinsic disorder in protein domains and families: I. A database of conserved predicted disordered regions. J Proteome Res (2006) 1.42
RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol (2008) 1.41
Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med (2003) 1.41
Solution structure of a ubiquitin-like domain from tubulin-binding cofactor B. J Biol Chem (2004) 1.40
A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas. Immunology (2015) 1.40
Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med (2004) 1.40
Don't count your interleukins before they've hatched. Trends Immunol (2002) 1.40
The Southeast Collaboratory for Structural Genomics: a high-throughput gene to structure factory. Acc Chem Res (2003) 1.39
IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol (2009) 1.39
The VQ motif protein IKU1 regulates endosperm growth and seed size in Arabidopsis. Plant J (2010) 1.38
Heat shock cognate protein 70 is involved in rotavirus cell entry. J Virol (2002) 1.37
Rotavirus gene silencing by small interfering RNAs. EMBO Rep (2002) 1.36
Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. Proc Natl Acad Sci U S A (2005) 1.36
Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol (2007) 1.36
Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial. J Bone Miner Res (2013) 1.36
Crystal structure of the oligomerization domain of the phosphoprotein of vesicular stomatitis virus. J Virol (2006) 1.35
A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog (2009) 1.35
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function. J Immunol (2010) 1.33
Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples. J Immunol Methods (2005) 1.33